Cencora (LTS:0HF3) YoY EBITDA Growth : 0.86% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Cencora YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Cencora's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 0.86%.

Cencora's EBITDA per Share for the three months ended in Mar. 2024 was $4.09.

Cencora YoY EBITDA Growth Historical Data

The historical data trend for Cencora's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora YoY EBITDA Growth Chart

Cencora Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

YoY EBITDA Growth

Get a 7-Day Free Trial

-9.38

-402.72

160.22

5.96

12.90

Cencora Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															-10.67	39.33	34.12	38.05	0.86

Cencora YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Cencora's YoY EBITDA Growth for the fiscal year that ended in Sep. 2023 is calculated as:

	YoY EBITDA Growth (A: Sep. 2023 )
=	(EBITDA per Share (A: Sep. 2023 )	-	EBITDA per Share (A: Sep. 2022 ))	/	\| EBITDA per Share (A: Sep. 2022 ) \|
=	(16.703	-	14.795)	/	\| 14.795 \|
=	12.90 %

Cencora's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(4.094	-	4.059)	/	\| 4.059 \|
=	0.86 %

Cencora YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Cencora's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Cencora (LTS:0HF3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (LTS:0HF3) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

COR:USA ABG:Germany C1CO34:Brazil ABC:Austria

Address

1 West First Avenue, Conshohocken, PA, USA, 19428-1800

Website

https://www.cencora.com

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Cencora (LTS:0HF3) Headlines

No Headlines